Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.

We have developed an automated system for the preparation of highly concentrated 188Re-perrhenate, diethylenetriamine pentaacetic acid (DTPA) and mercaptoacetyltriglycine (MAG3). The three procedural steps include concentration of 188Re-perrhanerate, chelation and purification and sterilization. The steps are operated by a small micro-controller. The eluted 188Re-perrhenate of 15 GBq/18 ml from 37 GBq 188W/188Re-generator was concentrated to 1.2 ml in 10 +/- 0.5 min with a recovery yield of 95 +/- 1.5%. We obtained the highest radiochemical yield of 95.4 +/- 2.8% and 98.5 +/- 1.2% for 188Re-DTPA and MAG3 at the oil bath temperatures of 95-97 degrees C and 93-97 degrees C, respectively.

[1]  R Waksman,et al.  Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. , 1995, Circulation.

[2]  A. Yeung,et al.  Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial , 2002, The Lancet.

[3]  M. Hong,et al.  Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon. , 2001, Journal of the American College of Cardiology.

[4]  G. Cheon,et al.  Dosimetry of rhenium-188 diethylene triamine penta-acetic acid for endovascular intra-balloon brachytherapy after coronary angioplasty , 2000, European Journal of Nuclear Medicine.

[5]  F. Knapp,et al.  Rhenium-188-HEDP in the palliative treatment of bone metastases. , 2000, Cancer biotherapy & radiopharmaceuticals.

[6]  P. Fitzgerald,et al.  Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. , 2000, Circulation.

[7]  H. Biersack,et al.  Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases , 2000, European Journal of Nuclear Medicine.

[8]  F. Knapp,et al.  Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. , 1997, Anticancer research.

[9]  M. Schwaiger,et al.  Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon. , 2001, The American journal of cardiology.

[10]  S. Mirzadeh,et al.  Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  C. Choi,et al.  Automation of the synthesis of highly concentrated 188Re-MAG3 for intracoronary radiation therapy. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[12]  M. Leon,et al.  Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis , 2000 .

[13]  B. Hsieh,et al.  Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis , 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.